These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34238151)

  • 1. Prediction Mechanism of Nevadensin as Antibacterial Agent against
    Shadrina AAN; Herdiyati Y; Wiani I; Satari MH; Kurnia D
    Comb Chem High Throughput Screen; 2022; 25(9):1488-1497. PubMed ID: 34238151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Fatty Acid as Antibacterial Agent Against Oral Bacteria of Streptococcus mutans and Streptococcus sanguinis from Basil (Ocimum americanum): In vitro and In silico Studies.
    Herdiyati Y; Astrid Y; Shadrina AAN; Wiani I; Satari MH; Kurnia D
    Curr Drug Discov Technol; 2021; 18(4):532-541. PubMed ID: 32652913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Nevadensin from
    Putri SA; Nur Shadrina AA; Julaeha E; Kurnia D
    Comb Chem High Throughput Screen; 2023; 26(9):1746-1754. PubMed ID: 36200248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Allylpyrocatechol Derivatives as Antibacterial Agent Against Oral Pathogen of
    Kurnia D; Hutabarat GS; Windaryanti D; Herlina T; Herdiyati Y; Satari MH
    Drug Des Devel Ther; 2020; 14():2977-2985. PubMed ID: 32801638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bio-Mechanism Inhibitory Prediction of β-Sitosterol from Kemangi (
    Evangelina IA; Herdiyati Y; Laviana A; Rikmasari R; Zubaedah C; Anisah ; Kurnia D
    Adv Appl Bioinform Chem; 2021; 14():103-115. PubMed ID: 34188494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bio-Mechanism of Catechin as Pheromone Signal Inhibitor: Prediction of Antibacterial Agent Action Mode by In Vitro and In Silico Study.
    Kurnia D; Ramadhanty ZF; Ardani AM; Zainuddin A; Dharsono HDA; Satari MH
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of MurA Enzyme and GBAP in Fsr Quorum Sensing System as Antibacterial Drugs Target: In vitro and In silico Study of Antibacterial Compounds from Myrmecodia pendans.
    Apriyanti E; Satari MH; Kurnia D
    Comb Chem High Throughput Screen; 2021; 24(1):109-118. PubMed ID: 32598250
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Ameen F; Orfali R; Mamidala E; Davella R
    Biotechnol Genet Eng Rev; 2023 Oct; 39(2):760-774. PubMed ID: 36578142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
    Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
    Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Molecular Docking Studies of Bioactive Principles from Alphonsea madraspatana Bedd. against Uropathogens.
    Sahu A; Ghosh G; Rath G
    Curr Pharm Biotechnol; 2020; 21(7):613-625. PubMed ID: 31914910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antibacterial activity of antibiotics and plant essential oils against Escherichia coli MTCC443 supported through the molecular docking and pharmacokinetics study.
    Jain S; Shukla AK; Panwar S; Kumar R; Kumar A
    Biotechnol Appl Biochem; 2024 Aug; 71(4):868-880. PubMed ID: 38627930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial Flavonoids Against Oral Bacteria of Enterococcus Faecalis ATCC 29212 from Sarang Semut (Myrmecodia pendans) and Its Inhibitor Activity Against Enzyme MurA.
    Kurnia D; Apriyanti E; Soraya C; Satari MH
    Curr Drug Discov Technol; 2019; 16(3):290-296. PubMed ID: 30152286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of new 1,2,3-triazolyl-quinolinyl-propan-2-ol derivatives as potential antimicrobial agents:
    Shinde AD; Nandurkar YM; Bhalekar S; Walunj YS; Ugale S; Ahmad I; Patel H; Chavan AP; Mhaske PC
    J Biomol Struct Dyn; 2024; 42(3):1191-1207. PubMed ID: 37254438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational Approaches to Develop Isoquinoline Based Antibiotics through DNA Gyrase Inhibition Mechanisms Unveiled through Antibacterial Evaluation and Molecular Docking.
    Alagumuthu M; Muralidharan VP; Andrew M; Ahmed MH; Iyer SK; Arumugam S
    Mol Inform; 2018 Dec; 37(12):e1800048. PubMed ID: 30051592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure based in silico analysis of quinolone resistance in clinical isolates of Salmonella Typhi from India.
    Kumar M; Dahiya S; Sharma P; Sharma S; Singh TP; Kapil A; Kaur P
    PLoS One; 2015; 10(5):e0126560. PubMed ID: 25962113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Potential of 24-Propylcholestrol as Antibacterial Oral Bacteria of
    Windaryanti D; Gabriel CS; Hidayat IW; Zainuddin A; Dharsono HDA; Satari MH; Kurnia D
    Adv Appl Bioinform Chem; 2022; 15():99-111. PubMed ID: 36578792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and In Silico Molecular Docking Studies on Substituted Piperic Acid Derivatives as Inhibitors of Bacterial DNA Gyrase.
    Chopra B; Dhingra AK; Prasad DN; Bhardwaj S; Dubey S
    Curr Comput Aided Drug Des; 2020; 16(3):281-294. PubMed ID: 31288729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.
    Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of fluoroquinolones induced resistance in DNA gyrase of Mycobacterium tuberculosis.
    Pandey B; Grover S; Tyagi C; Goyal S; Jamal S; Singh A; Kaur J; Grover A
    J Biomol Struct Dyn; 2018 Feb; 36(2):362-375. PubMed ID: 28071975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of secondary metabolites from Crescentia cujete as promising antibacterial therapeutics targeting type 2A topoisomerases through molecular dynamics simulation.
    Aribisala JO; Abdulsalam RA; Dweba Y; Madonsela K; Sabiu S
    Comput Biol Med; 2022 Jun; 145():105432. PubMed ID: 35344868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.